January 12-15, 2026 | San Francisco Marriott Marquis, CA
On behalf of our parent company, Nippon Shinyaku Co., Ltd, we are seeking in-licensing opportunities in the therapeutic areas of Hematology, Orphan diseases and external innovation opportunities in the new modality approaches.